Skip to content

6-KAccepted May 22, 5:24 PM ET

NERVGEN PHARMA CORP. 6-K

NGENNERVGEN PHARMA CORP.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:24 PM

May 22, 2026

Filed

May 22, 2026

Documents

7

Size

474.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.